108 related articles for article (PubMed ID: 6395991)
1. Plasma insulin and glucose levels in diabetic patients undergoing continuous ambulatory peritoneal dialysis using insulin only in the dialysate.
Dolgos ET; Vidt DG; Schumacher OP; Gupta MK
Cleve Clin Q; 1984; 51(4):611-4. PubMed ID: 6395991
[No Abstract] [Full Text] [Related]
2. Intraperitoneal insulin during peritoneal dialysis for patients with diabetes and renal failure.
Krothapalli R; Patel HS; Lacke C; Payne W; Knight TF; Senekjian HO; Weinman EJ
South Med J; 1983 Apr; 76(4):512-4. PubMed ID: 6340216
[No Abstract] [Full Text] [Related]
3. [Intraperitoneal insulin therapy combined with continuous ambulatory peritoneal dialysis (CAPD)].
Nevalainen P; Lahtela J; Mustonen J; Pasternack A
Duodecim; 1996; 112(2):89-94. PubMed ID: 10590611
[No Abstract] [Full Text] [Related]
4. Intraperitoneal insulin in uraemic diabetics undergoing continuous ambulatory peritoneal dialysis.
Balducci A; Slama G; Rottembourg J; Baumelou A; Delage A
Br Med J (Clin Res Ed); 1981 Oct; 283(6298):1021-3. PubMed ID: 6794746
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of transperitoneal insulin transport.
Widerøe TE; Dahl KJ; Smeby LC; Balstad T; Cruischank-Flakne S; Følling I; Simondsen O; Ahlmen J; Jørstad S
Nephron; 1996; 74(2):283-90. PubMed ID: 8893142
[TBL] [Abstract][Full Text] [Related]
6. Effect of dialysate glucose load on plasma glucose and glucoregulatory hormones in CAPD patients.
Armstrong VW; Creutzfeldt W; Ebert R; Fuchs C; Hilgers R; Scheler F
Nephron; 1985; 39(2):141-5. PubMed ID: 3883205
[TBL] [Abstract][Full Text] [Related]
7. Insulin prescription, glycemic control, and diabetic complications in diabetics treated by continuous ambulatory peritoneal dialysis.
Rottembourg J; Issad B; Allouache M
Perit Dial Int; 1993; 13 Suppl 2():S232-5. PubMed ID: 8399575
[No Abstract] [Full Text] [Related]
8. Transfer of native insulin through the peritoneal membrane during CAPD in non-diabetic and diabetic patients.
Ersoy FF; Karayalcin U; Karayalcin B; Sapan M; Bozcuk H; Süleymanlar G; Yakupoglu G
Adv Perit Dial; 1995; 11():119-22. PubMed ID: 8534683
[TBL] [Abstract][Full Text] [Related]
9. Intraperitoneal insulin in the diabetic continuous ambulatory peritoneal dialysis (CAPD) patient - nursing management.
Adair CM
AANNT J; 1982 Apr; 9(2):62-3. PubMed ID: 7039632
[No Abstract] [Full Text] [Related]
10. Continuous ambulatory peritoneal dialysis. Technique of catheter insertion and management of associated surgical complications.
Olcott C; Feldman CA; Coplon NS; Oppenheimer ML; Mehigan JT
Am J Surg; 1983 Jul; 146(1):98-102. PubMed ID: 6869687
[TBL] [Abstract][Full Text] [Related]
11. Intermediary metabolism and glycemic control in insulin-dependent diabetic uremic patients treated by continuous peritoneal dialysis.
Spotti D; Slaviero G; La Rocca E; Cantaluppi A; Castelnovo C; Micossi P; Quartagno R; Melandri M; Pozza G; Ponticelli C
Nephron; 1988; 49(3):219-22. PubMed ID: 3041295
[TBL] [Abstract][Full Text] [Related]
12. Efficiency of high volume low frequency continuous ambulatory peritoneal dialysis (CAPD).
Twardowski ZJ; Nolph KD; Prowant BF; Moore HL
Trans Am Soc Artif Intern Organs; 1983; 29():53-7. PubMed ID: 6673281
[No Abstract] [Full Text] [Related]
13. [Permanent control of blood glucose in diabetic patients using continuous ambulatory peritoneal dialysis. Continuous insulin infusion by the intraperitoneal route].
Martinand A; Belleville I; Cabanne JF; Chuet C; Morey W; Brun JM; Rifle G
Presse Med; 1984 Jan; 13(3):165. PubMed ID: 6229747
[No Abstract] [Full Text] [Related]
14. [Double-bag CAPD with intraperitoneal insulin. Satisfactory management of diabetes and its major complications in uremic patients].
Bazzato G; Lucatello S; Coli U; Landini S; Fracasso A; Morachiello P; Fabbro A
Minerva Nefrol; 1981; 28(3):345-52. PubMed ID: 7036017
[No Abstract] [Full Text] [Related]
15. Intraperitoneal (125I) insulin absorption during intermittent and continuous peritoneal dialysis.
Wideröe TE; Smeby LC; Berg KJ; Jörstad S; Svartås TM
Kidney Int; 1983 Jan; 23(1):22-8. PubMed ID: 6339786
[No Abstract] [Full Text] [Related]
16. Glucose, insulin and C-peptide kinetics during continuous ambulatory peritoneal dialysis.
Wideröe TE; Smeby LC; Myking OL; Wessel-Aas T
Proc Eur Dial Transplant Assoc; 1983; 20():195-200. PubMed ID: 6361735
[TBL] [Abstract][Full Text] [Related]
17. Insulin therapy during peritoneal dialysis: pros and cons of various forms of administration.
Quellhorst E
J Am Soc Nephrol; 2002 Jan; 13 Suppl 1():S92-6. PubMed ID: 11792768
[TBL] [Abstract][Full Text] [Related]
18. Peritonitis during continuous ambulatory peritoneal dialysis: improving patient defense by type of buffer of dialysate?
Binswanger U; Keusch G; Bammatter F; Heule H; Kiss D
Nephron; 1981; 28(6):300-2. PubMed ID: 7312085
[No Abstract] [Full Text] [Related]
19. [Intermittent peritoneal chronic dialysis in diabetic patients: effect of the technique on blood glucose and protein loss during the procedure].
García Ortiz R; Gómez M; Olea C
Rev Med Chil; 1989 Dec; 117(12):1367-73. PubMed ID: 2519375
[TBL] [Abstract][Full Text] [Related]
20. A comparison of glucose polymer and dextrose containing dialysate in CAPD patients.
Gross ML; Somani P; Higgins JT
Trans Am Soc Artif Intern Organs; 1984; 30():483-5. PubMed ID: 6533926
[No Abstract] [Full Text] [Related]
[Next] [New Search]
